Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Apr 20, 09:26

Vir Biotechnology, Inc. (NASDAQ:VIR) Short Interest Up 28.3% in March

Vir Biotechnology Inc
Webhose 2025 Apr 20, 08:36

Walleye Capital LLC Increases Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 20, 07:52

Renaissance Technologies LLC Buys 55,300 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 10, 05:00

New Mpro inhibitors revealed in Vir Biotechnology patent | BioWorld

Vir Biotechnology Inc
Webhose 2025 Apr 09, 16:06

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year Low - Here's Why

Vir Biotechnology Inc
Webhose 2025 Apr 09, 13:43

Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple

Vir Biotechnology Inc
Webhose 2025 Apr 09, 11:13

ADAR1 Capital Management LLC Sells 255,118 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 09, 00:00

Hepatitis B Virus (HBV) Infection Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | ABNewswire

Vir Biotechnology Inc
Webhose 2025 Apr 06, 08:03

Vir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells $474,286.40 in Stock

Vir Biotechnology Inc
Webhose 2025 Apr 06, 07:35

Prudential Financial Inc. Sells 180,800 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 31, 13:42

Vir Biotechnology Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution

Vir Biotechnology Inc
Webhose 2025 Mar 31, 00:00

Authority Investment Dhabi Abu - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 Mar 30, 10:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2025 Mar 30, 08:59

Artisan Partners Limited Partnership Makes New Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 30, 08:26

WINTON GROUP Ltd Reduces Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 29, 00:52

Vir Biotechnology (NASDAQ:VIR) Reaches New 1-Year Low - Here's Why

Vir Biotechnology Inc
Webhose 2025 Mar 28, 12:24

Vir Biotechnology, Inc. (NASDAQ:VIR) is favoured by institutional owners who hold 53% of the company

Vir Biotechnology Inc
Webhose 2025 Mar 27, 08:41

Fox Run Management L.L.C. Takes $364,000 Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 27, 08:32

49,651 Shares in Vir Biotechnology, Inc. (NASDAQ:VIR) Acquired by Fox Run Management L.L.C.

Vir Biotechnology Inc

Latest news

Frances Wang 2025 Apr 22, 16:00

Commodity market today: Crude Oil Fluctuates as OPEC+ Modifies Production Goals

Commodities
Tommy Yap 2025 Apr 22, 16:00

Morning Note: Trump Calms Fed Fears; Tesla Disappoints; UK Trade Talks Begin

Morning Note Tech
Frances Wang 2025 Apr 21, 16:00

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Stocks Indices
Tommy Yap 2025 Apr 21, 16:00

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Morning Note Stocks Commodities
Frances Wang 2025 Apr 20, 16:00

Gold Price Today: XAU/USD Over $3,350 on Trump's Tariff Policies Uncertainty

Commodities
Tommy Yap 2025 Apr 20, 16:00

Morning Note: Dollar Falls on Trump-Fed Fears; Japan in US Trade Talks; China holds rates

Morning Note Forex
Tommy Yap 2025 Apr 19, 16:00

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Forex Indices
Frances Wang 2025 Apr 17, 16:00

Stock market today: Nifty above 24,400, Sensex up 309 points

Stocks Indices

Info

Spread

0.05

Spread (%)

0.8389 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

800771200

Shares Outstanding

138064000

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.83

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot